The European metropolitan area of Munich is the leading biotechnology location in Germany and enjoys a leading position in Europe. History
About 250 life sciences companies including 130 SMEs
2 elite-universities: Ludwig-Maximilians-Universität and Technische Universität München
Helmholtz Zentrum München – German Research Center for Environmental Health
3 biological/medical Max Planck Institutes: biochemistry, neurobiology und psychiatry
2 university hospitals: Klinikum rechts der Isar and Klinikum der Universität München as well as 60 other hospitals
2 Innovation- and start-up centers specializing in biotechnology
The location is particularly benefiting from close networking between academic research and the biotech industry. The majority of medium-sized biotechnology companies are spin-offs of scientific institutions. The region is dynamic: over the last five years there have been around 40 new start-ups. The region is concentrated: companies emphasize "red biotechnology", that is: the development of therapeutics and diagnostics. Its special powers are personalized medicine and immunotherapy.
The Biotechnology Innovation and Start-up Centers (IZB) offer state-of-the-art laboratories and office space for young biotechnology companies. The start-ups benefit from the contacts and the creative environment in the incubator and from the proximity to academic research at the universities in Weihenstephan and Martinsried.
IZB Planegg-Martinsried specializes in pharmaceuticals and services
IZB Freising-Weihenstephan specializes in phyto-pharmaceuticals, agronomical and food
A total of more than 25,000 sqm is available.
An overview of the metropolitan area of Munich as the leading biotechnology location in Germany.
